Bluejay Announces Abstract Accepted for Presentation at the 2026 Society of Academic Emergency Medicine (SAEM) Annual Meeting

Core Insights - Bluejay Diagnostics, Inc. announced that an abstract related to its Symphony™ IL-6 Test has been accepted for presentation at the 2026 Society of Academic Emergency Medicine Annual Meeting [1] - The SYMON-I study evaluates the relationship between IL-6 levels in sepsis patients and organ dysfunction, measured by SOFA scores during the first three days of hospitalization [2][3] Study Details - SYMON-I is a multicenter pilot clinical study focusing on IL-6 levels in sepsis patients admitted to the ICU [2] - The study aims to determine if IL-6 levels can serve as a biomarker for early assessment of organ dysfunction in critically ill patients [3] Presentation Information - The presentation titled "Emergency Department Interleukin-6 Levels and Organ Dysfunction in Sepsis Across Multiple Centers" will be delivered by Dr. John H. Lee and Dr. Nathan Shapiro at the SAEM Annual Meeting in Atlanta, Georgia [4] Product Information - The Symphony™ IL-6 Test is designed for rapid assessment of patient acuity for sepsis triage and monitoring, providing results in approximately 20 minutes [8] - Bluejay's ongoing SYMON-II study aims to validate the findings of SYMON-I and support a 510(k) application to the FDA [6] Company Overview - Bluejay Diagnostics focuses on improving patient outcomes through its Symphony System, which is a cost-effective, rapid testing system for sepsis [8]